LLY (NYSE) - Eli Lilly and Company

Exchange: USA Stocks • Country: USA • Currency: USD • Type: Common Stock • ISIN: US5324571083
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. Web URL: https://www.lilly.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for LLY (NYSE) - Eli Lilly and Company
Market Cap. 419,892m USD
GiC Sector Health Care
GiC Industry Pharmaceuticals
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1978-01-13


Fundamental 4.54
Dividend 9.11
Performance 5y 8.97
Performance TTM 10.00
Relative Performance 5.11
Analysts 4.17
Price / Fair Price TR 0.85
Price / Fair Price DCF todo


Growth TTM 43.84%
CAGR 5y 41.52%
CAGR / Mean Drawdown 5y 6.68
Sharpe Ratio TTM 1.51
Alpha vs SP500 TTM 40.12
Beta vs SP500 5y weekly 0.61
CAPM 7.94%
Average Daily Range % 2.13%
Volatility GJR Garch 1y 26.10%
Max Drawdown 5y 22%
Mean Drawdown 5y 6.2%
Price / SMA 50 10.46%
Price / SMA 200 25.86%
Current Volume 1669.3k
Average Volume 3162.2k


Rate TTM 4.22
Yield TTM 0.97%
Div. CAGR 5y 11.74%
Consistency of Dividends all time 99.8%